Dendritic cell/tumor hybrids enhances therapeutic efficacy against colorectal cancer liver metastasis in SCID mice

References

• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71–96.
   PubMed Web of Science ®Google Scholar
• Cromheecke M, de Jong KP, Hoekstra HJ. Current treatment for colorectal cancer metastatic to the liver. Eur J Surg Oncol 1999;25:451–63.
   PubMedGoogle Scholar
• Steele G Jr, Ravikumar TS. Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg 1989;210:127–38.
   PubMed Web of Science ®Google Scholar
• Ruers T, Bleichrodt RP. Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 2002;38:1023–33.
   PubMed Web of Science ®Google Scholar
• Gong J, Chen L, Chen D, Kashiwaba M, Manome Y, Tanaka T, Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells. Gene Ther 1997;4:1023–8.
   PubMed Web of Science ®Google Scholar
• Specht JM, Wang G, Do MT, Lam JS, Royal RE, Reeves ME, Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases. J Exp Med 1997;186:1213–21.
   PubMed Web of Science ®Google Scholar
• Rains N, Cannan RJ, Chen W, Stubbs RS. Development of a dendritic cell (DC)-based vaccine for patients with advanced colorectal cancer. Hepatogastroenterology 2001;48:347–51.
   PubMed Web of Science ®Google Scholar
• Condon C, Watkins SC, Celluzzi CM, Thompson K, Falo LD Jr. DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 1996;2:1122–8.
   PubMed Web of Science ®Google Scholar
• Song W, Kong HL, Carpenter H, Torii H, Granstein R, Rafii S, Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity. J Exp Med 1997;186:1247–56.
   PubMed Web of Science ®Google Scholar
• Ribas A, Butterfield LH, McBride WH, Jilani SM, Bui LA, Vollmer CM, Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells. Cancer Res 1997;57:2865–9.
   PubMed Web of Science ®Google Scholar
• Gong J, Chen D, Kashiwaba M, Kufe D. Induction of antitumor activity by with fusions of dendritic and carcinoma cells. Nat Med 1997;3:558–61.
   PubMed Web of Science ®Google Scholar
• Gong J, Avigan D, Chen D, Wu Z, Koido S, Kashiwaba M, Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells. Proc Natl Acad Sci USA 2000;97:2715–8.
   PubMed Web of Science ®Google Scholar
• Wang J, Saffold S, Cao X, Krauss J, Chen W. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines. J Immunol 1998;161:5516–24.
   PubMed Web of Science ®Google Scholar
• Chen D, Xia J, Tanaka Y, Chen H, Koido S, Wernet O, Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cells. Immunology 2003;109:300–7.
   PubMed Web of Science ®Google Scholar
• Kawada M, Ikeda H, Takahashi T, Ishizu A, Ishikura H, Katoh H, Vaccination of fusion cells of rat dendritic and carcinoma cells prevents tumor growth in vivo. Int J Cancer 2003;105:520–6.
   PubMedGoogle Scholar
• Avigan D, Vasir B, Gong J, Borges V, Wu Z, Uhl L, Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses. Clin Cancer Res 2004;10:4699–708.
   PubMed Web of Science ®Google Scholar
• Raje N, Hideshima T, Davies FE, Chauhan D, Treon SP, Young G, Tumor cell/dendritic cell fusion as a vaccination strategy for multiple myeloma. Br J Haematol 2004;125:343–52.
   PubMed Web of Science ®Google Scholar
• Xu F, Ye YJ, Cui ZR, Wang S. Allogeneic dendritomas induce anti-tumour immunity against metastatic colon cancer. Scand J Immunol 2005;61:364–9.
   PubMedGoogle Scholar
• Kuruppu D, Christophi C, Bertram JF, O'Brien PE. Characterization of an animal model of hepatic metastasis. J Gastroenterol Hepatol 1996;11:26–32.
   PubMedGoogle Scholar
• Xu F, Ye YJ, Wang S. In vitro antitumor immune response induced by fusion of dendritic cells and colon cancer cells. World J Gastroenterol 2004;10:1162–6.
   PubMed Web of Science ®Google Scholar
• Jäger E, Gnjatic S, Nagata Y, Stockert E, Jäger D, Karbach J, Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proc Natl Acad Sci USA 2000;97:12198–203.
   PubMed Web of Science ®Google Scholar
• Atkins D, Breuckmann A, Schmahl GE, Binner P, Ferrone S, Krummenauer F, MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma. Int J Cancer 2004;109:265–73.
   PubMed Web of Science ®Google Scholar
• Araibi EH, Marchetti B, Ashrafi GH, Campo MS. Downregulation of major histocompatibility complex class I in bovine papillomas. J Gen Virol 2004;85(Pt 10):2809–14.
   PubMedGoogle Scholar
• Muris JJ, Meijer CJ, Cillessen SA, Vos W, Kummer JA, Bladergroen BA, Prognostic significance of activated cytotoxic T lymphocytes in primary nodal diffuse large B-cell lymphomas. Leukemia 2004;18:589–96.
   PubMed Web of Science ®Google Scholar
• Shu S, Cohen P. Tumor-dendritic cell fusion technology and immunotherapy strategies. J immunother 2001;24:99–100.
   Web of Science ®Google Scholar
• Hsueh EC, Nathanson L, Foshag LJ, Essner R, Nizze JA, Stern SL, Active specific immunotherapy with polyvalent melanoma cell vaccine for patients with in-transit melanoma metastases. Cancer 1999;85:2160–9.
   PubMed Web of Science ®Google Scholar
• Chan RC, Xie H, Zhao GP, Xie Y. Dendritomas formed by fusion of mature dendritic cells with allogenic human hepatocellular carcinoma cells activate autologous cytotoxic T lymphocytes. Immunol Lett 2002;83:101–9.
   PubMedGoogle Scholar
• Trevor KT, Cover C, Ruiz YW, Akporiaye ET, Hersh EM, Landais D, Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application. Cancer Immunol Immunother 2004;53:705–14.
   PubMed Web of Science ®Google Scholar
• Gong J, Nikrui N, Chen D, Koido S, Wu Z, Tanaka Y, Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity. J Immunol 2000;165:1705–11.
   PubMed Web of Science ®Google Scholar
• Fifis T, Lam I, Lin D, Malcontenti-Wilson C, Christophi C, Loveland B. Vaccination with in vitro grown whole tumor cells induces strong immune responses and retards tumor growth in a murine model of colorectal liver metastases. Vaccine 2008;26:241–9.
   PubMedGoogle Scholar
• Ohtani H. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. Cancer Immun 2007;7:4.
   PubMedGoogle Scholar
• Srivastava PK, Deleo AB, Old LJ. Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc Natl Acad Sci USA 1986;83:3407–11.
   PubMed Web of Science ®Google Scholar